Article and Video CATEGORIES

Cancer Journey

Search By

ABOUT
Denise Brock

Denise has over 30 years of varying experience in the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.  

 

Registration is Now Open for the 2019 Targeted Therapies Live Patient Forum
dbrock
Join GRACE Live in Philadelphia for the 2019 Targeted Therapies Patient Forum
Author
Denise Brock
Image

Register Now for the Targeted Therapies Patient Forum


Join our faculty April 6, 2019, in Philadelphia, PA to learn about the newest breakthroughs in Targeted Therapies for Lung Cancer 

Have a chance to talk with the doctors about the newest information in targeted therapies.  Some potential topics our faculty will be discussing include:

 

NGS: Current Status, Barriers and Emerging Targets
Liquid Biopsies as a New Option: How Does it Fit In?

What is the Role for Rebiopsy Today?

Presentations by Lung Cancer Subtypes - ALK, ROS1, EGFR, RET,MET, BRAF

Immunotherapy for Targeted Therapies - What Do We Know?

Controlling the Brain as a Separate Compartment

Online Communities - Support, Education & Partnership on Research

and time for discussion and Q&A

(**subject to change)


 
We hope to see you there!  Register Now!

 
 

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

Hi app.92,  Welcome to Grace.  I'm sorry this is late getting to you. And more sorry your mum is going through this.  It's possible this isn't a pancoast tumor even though...

A Brief Tornado.  I love the analogy Dr. Antonoff gave us to describe her presentation.  I felt it earlier too and am looking forward to going back for deeper dive.

Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".

While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".  

I hope any...

My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.

Here's the webinar on YouTube.  It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Recent Comments

JOIN THE CONVERSATION
Hi app.92,  Welcome to Grace…
By JanineT GRACE … on
Webinar OnDemand
By JanineT GRACE … on
My understanding of ADCs is…
By JanineT GRACE … on
Right patient, right time,…
By JanineT GRACE … on